Cargando…
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?
Nonalcoholic fatty liver disease (NAFLD) is defined by hepatic steatosis in the presence of alcohol intake within safe limits, defined by guidelines of scientific associations (usually 20 g or 2 units/day in women, 30 g or 3 units in men). The diagnosis is usually followed by medical counseling of t...
Autores principales: | Petroni, Maria L., Brodosi, Lucia, Marchignoli, Francesca, Musio, Alessandra, Marchesini, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950084/ https://www.ncbi.nlm.nih.gov/pubmed/31847199 http://dx.doi.org/10.3390/nu11123048 |
Ejemplares similares
-
The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
por: Choi, Jong Hwa, et al.
Publicado: (2020) -
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs
por: Petroni, Maria Letizia, et al.
Publicado: (2023) -
Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease
por: Kwon, Inbeom, et al.
Publicado: (2019) -
Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges
por: Petroni, Maria Letizia, et al.
Publicado: (2021) -
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real‐world data analysis
por: Colosimo, Santo, et al.
Publicado: (2021)